BBW
ABBV icon

Blue Barn Wealth’s AbbVie ABBV Stock Holding History

Blue Barn Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,448
Closed -$335K – 47
2025
Q3 		$335K Buy
1,448
+23
+2% +$4.68K 0.15% 101
2025
Q2 		$264K Buy
1,425
+145
+11% +$26.9K 0.12% 127
2025
Q1 		$268K Buy
1,280
+7
+0.5% +$1.36K 0.14% 112
2024
Q4 		$226K Buy
1,273
+103
+9% +$18.9K 0.12% 131
2024
Q3 		$231K Sell
1,170
-3
-0.3% -$560 0.12% 135
2024
Q2 		$201K Buy
+1,173
New +$194K 0.11% 133
2024
Q1 		– Sell
-1,482
Closed -$230K – 136
2023
Q4 		$230K Sell
1,482
-700
-32% -$102K 0.14% 100
2023
Q3 		$325K Buy
2,182
+76
+4% +$11.2K 0.21% 82
2023
Q2 		$284K Sell
2,106
-175
-8% -$25.7K 0.18% 88
2023
Q1 		$364K Buy
2,281
+149
+7% +$22.8K 0.23% 77
2022
Q4 		$345K Buy
2,132
+596
+39% +$91.4K 0.23% 73
2022
Q3 		$206K Buy
+1,536
New +$220K 0.15% 109
2022
Q2 		– Sell
-1,391
Closed -$225K – 115
2022
Q1 		$225K Sell
1,391
-220
-14% -$32K 0.16% 109
2021
Q4 		$218K Buy
+1,611
New +$190K 0.15% 113

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Blue Barn Wealth's ABBV Position: Q4 2025 in Review

Blue Barn Wealth sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 1,448 shares — an estimated $335K sold.

Blue Barn Wealth first reported a position in ABBV in Q4 2021 and held it in 14 quarters. The position peaked at $364K in Q1 2023. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Blue Barn Wealth reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Blue Barn Wealth sold 1,448 AbbVie shares in Q4 2025, an estimated $335K.
  • Blue Barn Wealth first reported a position in AbbVie in Q4 2021 and held it in 14 quarters.
  • Blue Barn Wealth's AbbVie position peaked at $364K in Q1 2023.
  • 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Blue Barn Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.